Pluristem (TA:PSTI) — Market Cap & Net Worth
Market Cap & Net Worth: Pluristem (PSTI)
Pluristem (TA:PSTI) has a market capitalization of $32.23 Million (ILA12.02 Billion) as of September 17, 2026. Listed on the TA stock exchange, this Israel-based company holds position #23603 globally and #329 in its home market, demonstrating a -11.73% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pluristem's stock price ILA371.60 by its total outstanding shares 32347600 (32.35 Million). Also see Pluristem (PSTI) total assets for a full breakdown of the balance sheet.
Pluristem Market Cap History: 2015 to 2026
Pluristem's market capitalization history from 2015 to 2026. Data shows change from $3.90 Billion to $32.23 Million (-37.95% CAGR). Also see PSTI cash flow conversion for how efficiently the company converts equity into cash flow.
Pluristem Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pluristem's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Pluristem (PSTI) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
8559.16x
Pluristem's market cap is 8559.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $3.90 Billion | $379.00K | -$24.68 Million | 10296.90x | N/A |
| 2016 | $4.82 Billion | $2.85 Million | -$23.25 Million | 1693.94x | N/A |
| 2018 | $2.47 Billion | $50.00K | -$26.13 Million | 49431.99x | N/A |
| 2019 | $118.55 Million | $54.00K | -$35.31 Million | 2195.37x | N/A |
| 2020 | $196.86 Million | $23.00K | -$29.15 Million | 8559.16x | N/A |
Competitor Companies of PSTI by Market Capitalization
Companies near Pluristem in the global market cap rankings as of September 17, 2026. Review Pluristem tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Pluristem by market ranking:
- Peptron Inc (KQ:087010): Ranked #7067 globally with a market cap of $1.57 Billion USD ( ₩2.31 Trillion KRW).
- Bioneer Corporation (KQ:064550): Ranked #17802 globally with a market cap of $147.65 Million USD ( ₩217.88 Billion KRW).
- Panagene Inc (KQ:046210): Ranked #24413 globally with a market cap of $25.48 Million USD ( ₩37.60 Billion KRW).
- MEDIPOST Co. Ltd (KQ:078160): Ranked #19636 globally with a market cap of $90.68 Million USD ( ₩133.80 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #7067 | Peptron Inc | KQ:087010 | $1.57 Billion | ₩150800.00 |
| #17802 | Bioneer Corporation | KQ:064550 | $147.65 Million | ₩9860.00 |
| #24413 | Panagene Inc | KQ:046210 | $25.48 Million | ₩1170.00 |
| #19636 | MEDIPOST Co. Ltd | KQ:078160 | $90.68 Million | ₩8700.00 |
Pluristem Historical Marketcap From 2015 to 2026
Between 2015 and today, Pluristem's market cap moved from $3.90 Billion to $ 32.23 Million, with a yearly change of -37.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA32.23 Million | -61.16% |
| 2025 | ILA82.98 Million | -38.98% |
| 2024 | ILA135.98 Million | +668.25% |
| 2023 | ILA17.70 Million | -39.44% |
| 2022 | ILA29.23 Million | -28.74% |
| 2021 | ILA41.01 Million | -79.17% |
| 2020 | ILA196.86 Million | +66.06% |
| 2019 | ILA118.55 Million | -95.20% |
| 2018 | ILA2.47 Billion | -39.94% |
| 2017 | ILA4.11 Billion | -14.67% |
| 2016 | ILA4.82 Billion | +23.58% |
| 2015 | ILA3.90 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Pluristem was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.23 Million USD |
| MoneyControl | $32.23 Million USD |
| MarketWatch | $32.23 Million USD |
| marketcap.company | $32.23 Million USD |
| Reuters | $32.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Pluristem
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase I… Read more